Skip to main content

Find Clinical Trials

Home
Conditions
Diabetes Mellitus, Type 2

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 157 recruiting studies

Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s)

NCT00653341

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Sanofi-aventis administrative office Bridgewater, New Jersey, United States

Sanofi-aventis administrative office Laval, Canada

View Trial Details

Completed

Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients

NCT00174824

Conditions: Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +10 more
Locations: Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States

Sanofi-Aventis Administrative Office Laval, Canada

View Trial Details

Completed

Long-Term Safety Study of Vildagliptin in Patients With Type 2 Diabetes

NCT00325429

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Novartis Pharmaceuticals Tokyo, Japan

View Trial Details

Completed

Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by Diet

NCT00118950

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Steno Diabetes Center Gentofte Municipality, Denmark

View Trial Details

Completed

Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes

NCT00118963

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Steno Diabetes Center Gentofte Municipality, Denmark

View Trial Details

Completed

Long Term Safety of Vildagliptin (100mg qd) In Patients With Type 2 Diabetes

NCT00389415

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: Novartis Pharmaceuticals Tokyo, Japan

View Trial Details

Completed

An Online System to Improve Diabetes Self-Care

NCT00119938

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

View Trial Details

Completed

Effectiveness and Safety Study of the Next-Generation DexCom™ SEVEN® Continuous Glucose Monitoring System

NCT00722241

Conditions: Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations: John Muir Physician Network Clinical Research Center Concord, California, United States

Advanced Metabolic Care + Research Escondido, California, United States

Sansum Diabetes Research Institute Santa Barbara, California, United States

View Trial Details

Completed

Lifestyle Intervention's Impact on Health Care Costs

NCT00717158

Conditions: Behavior, Body Weight, Diabetes Mellitus, +12 more
Locations: University of Virginia School of Medicine Charlottesville, Virginia, United States

View Trial Details

Completed

A Study for Patients With Type 2 Diabetes Mellitus

NCT00490854

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukushima, Japan

View all 13 locations

View Trial Details